Rick Doblin

And he's become very passionate about what he's seen from those people that have done, the veterans that have done MDMA-assisted therapy inside the Veterans Administration. But it took MAPS 25 years. Starting in 1995, we were offering money to the VA to do MDMA research until 2021 when the first veteran received MDMA inside the VA from VA therapists.

And he's become very passionate about what he's seen from those people that have done, the veterans that have done MDMA-assisted therapy inside the Veterans Administration. But it took MAPS 25 years. Starting in 1995, we were offering money to the VA to do MDMA research until 2021 when the first veteran received MDMA inside the VA from VA therapists.

And he's become very passionate about what he's seen from those people that have done, the veterans that have done MDMA-assisted therapy inside the Veterans Administration. But it took MAPS 25 years. Starting in 1995, we were offering money to the VA to do MDMA research until 2021 when the first veteran received MDMA inside the VA from VA therapists.

So talk about frustration. Think about the number of people that have committed suicide from when we started offering to the VA to do it. But it was the propaganda. It was the stigma that made it so that they were not willing to do it. What's most amazing today is that Congress gave $10 million to to the Department of Defense for MDMA-assisted therapy research in active-duty soldiers.

So talk about frustration. Think about the number of people that have committed suicide from when we started offering to the VA to do it. But it was the propaganda. It was the stigma that made it so that they were not willing to do it. What's most amazing today is that Congress gave $10 million to to the Department of Defense for MDMA-assisted therapy research in active-duty soldiers.

So talk about frustration. Think about the number of people that have committed suicide from when we started offering to the VA to do it. But it was the propaganda. It was the stigma that made it so that they were not willing to do it. What's most amazing today is that Congress gave $10 million to to the Department of Defense for MDMA-assisted therapy research in active-duty soldiers.

So there's a $4.9 million grant that went to Dr. Aaron Wolfgang at Walter Reed, and it's going to be giving MDMA-assisted therapy. There's another $4.9 million grant that went to a group called StrongStar that's in San Antonio here in Texas, elsewhere, and they're connected with Emory University.

So there's a $4.9 million grant that went to Dr. Aaron Wolfgang at Walter Reed, and it's going to be giving MDMA-assisted therapy. There's another $4.9 million grant that went to a group called StrongStar that's in San Antonio here in Texas, elsewhere, and they're connected with Emory University.

So there's a $4.9 million grant that went to Dr. Aaron Wolfgang at Walter Reed, and it's going to be giving MDMA-assisted therapy. There's another $4.9 million grant that went to a group called StrongStar that's in San Antonio here in Texas, elsewhere, and they're connected with Emory University.

And so they're going to combine MDMA with a therapy called prolonged exposure where you talk about the trauma over and over. But that's very re-traumatizing. There was a study that the Veterans Administration did that took them about six years. It was 916 veterans and it compared two therapies that they use, both non-drug therapies for treating PTSD. One was called prolonged exposure.

And so they're going to combine MDMA with a therapy called prolonged exposure where you talk about the trauma over and over. But that's very re-traumatizing. There was a study that the Veterans Administration did that took them about six years. It was 916 veterans and it compared two therapies that they use, both non-drug therapies for treating PTSD. One was called prolonged exposure.

And so they're going to combine MDMA with a therapy called prolonged exposure where you talk about the trauma over and over. But that's very re-traumatizing. There was a study that the Veterans Administration did that took them about six years. It was 916 veterans and it compared two therapies that they use, both non-drug therapies for treating PTSD. One was called prolonged exposure.

The other was cognitive processing therapy. And what they showed is that around half the people are in the study drop out because the therapy itself is re-traumatizing. Because you're just forced to go over the trauma, over the trauma, over and over, and that's supposed to desensitize you. And if you can stay in it, it can be helpful, but it re-traumatizes so many people.

The other was cognitive processing therapy. And what they showed is that around half the people are in the study drop out because the therapy itself is re-traumatizing. Because you're just forced to go over the trauma, over the trauma, over and over, and that's supposed to desensitize you. And if you can stay in it, it can be helpful, but it re-traumatizes so many people.

The other was cognitive processing therapy. And what they showed is that around half the people are in the study drop out because the therapy itself is re-traumatizing. Because you're just forced to go over the trauma, over the trauma, over and over, and that's supposed to desensitize you. And if you can stay in it, it can be helpful, but it re-traumatizes so many people.

we've shown is working with the MDMA with veterans, is that they're able to process the trauma, the fear reduction from the MDMA, reducing activity in the amygdala, the fear processing part of our brain, that you can, once you can approach these things that have felt like will tear you apart, that they'll be overwhelming, you can't really go away from them, but they never

we've shown is working with the MDMA with veterans, is that they're able to process the trauma, the fear reduction from the MDMA, reducing activity in the amygdala, the fear processing part of our brain, that you can, once you can approach these things that have felt like will tear you apart, that they'll be overwhelming, you can't really go away from them, but they never

we've shown is working with the MDMA with veterans, is that they're able to process the trauma, the fear reduction from the MDMA, reducing activity in the amygdala, the fear processing part of our brain, that you can, once you can approach these things that have felt like will tear you apart, that they'll be overwhelming, you can't really go away from them, but they never

really leave either, then you can process it. So this study that will be done here in Texas with active duty soldiers, again, is going to be a combination of MDMA with prolonged exposure. The Walter Reed study is combining MDMA with what they call acceptance and commitment therapy, different kind of approaches.

really leave either, then you can process it. So this study that will be done here in Texas with active duty soldiers, again, is going to be a combination of MDMA with prolonged exposure. The Walter Reed study is combining MDMA with what they call acceptance and commitment therapy, different kind of approaches.